# Systolic Hypertension in the Elderly Program (SHEP)

> **NCT00000514** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Cerebrovascular Disorders
- Heart Diseases
- Hypertension

## Interventions

- **DRUG:** chlorthalidone
- **DRUG:** atenolol
- **DRUG:** reserpine

## Key facts

- **NCT ID:** NCT00000514
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1984-06
- **Primary completion:** —
- **Final completion:** 1996-10
- **Target enrollment:** — (—)
- **Last updated:** 2016-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000514, "Systolic Hypertension in the Elderly Program (SHEP)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*